Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma

Endocr Relat Cancer. 2017 Feb;24(2):L7-L11. doi: 10.1530/ERC-16-0431. Epub 2016 Nov 28.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Paraganglioma / drug therapy*

Substances

  • Interferon-alpha